ARKK vs XLV: Which is better?
Quick Takeaway: XLV has a lower expense ratio (0.09%) than ARKK (0.75%), making it more cost-effective for long-term buy-and-hold investors.
Comparison Matrix
| Metric | ARKK (ARK Innovation ETF) | XLV (Health Care Select Sector SPDR Fund) |
|---|---|---|
| Asset Class | US Innovation Growth | US Healthcare |
| Expense Ratio | 0.75% | 0.09% |
| Dividend Yield | 0.00% | 1.55% |
| AUM | $6B | $39B |
| Benchmark | MSCI World Index | Health Care Select Sector Index |
